These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36223278)

  • 1. Effect of the human endotoxin challenge on tedizolid tissue penetration.
    Jorda A; Wulkersdorfer B; Schoergenhofer C; Matzneller P; Al Jalali V; Bauer M; Wölfl-Duchek M; Lackner E; Dorn C; Jilma B; Zeitlinger M
    Br J Clin Pharmacol; 2023 Jan; 89(1):416-420. PubMed ID: 36223278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of tedizolid on the cytokine response to the endotoxin challenge in healthy volunteers: a cross-over trial.
    Jorda A; Wulkersdorfer B; Schörgenhofer C; Matzneller P; Al Jalali V; Bauer M; Wölf-Duchek M; Lackner E; Dorn C; Jilma B; Zeitlinger M
    J Antimicrob Chemother; 2022 Apr; 77(5):1424-1431. PubMed ID: 35165727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin and soft tissue concentrations of tedizolid (formerly torezolid), a novel oxazolidinone, following a single oral dose in healthy volunteers.
    Sahre M; Sabarinath S; Grant M; Seubert C; Deanda C; Prokocimer P; Derendorf H
    Int J Antimicrob Agents; 2012 Jul; 40(1):51-4. PubMed ID: 22584101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Assessment of Tedizolid Pharmacokinetics and Tissue Penetration between Diabetic Patients with Wound Infections and Healthy Volunteers via
    Stainton SM; Monogue ML; Baummer-Carr A; Shepard AK; Nugent JF; Kuti JL; Nicolau DP
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary disposition of tedizolid following administration of once-daily oral 200-milligram tedizolid phosphate in healthy adult volunteers.
    Housman ST; Pope JS; Russomanno J; Salerno E; Shore E; Kuti JL; Nicolau DP
    Antimicrob Agents Chemother; 2012 May; 56(5):2627-34. PubMed ID: 22330925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of Tedizolid in Morbidly Obese and Covariate-Matched Nonobese Adults.
    Pai MP
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4585-9. PubMed ID: 27185808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics of tedizolid in rat plasma and cerebrospinal fluid.
    Gu L; Ma M; Zhang Y; Zhang L; Zhang S; Huang M; Zhang M; Xin Y; Zheng G; Chen S
    Regul Toxicol Pharmacol; 2019 Oct; 107():104420. PubMed ID: 31295511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of tedizolid in subjects with renal or hepatic impairment.
    Flanagan S; Minassian SL; Morris D; Ponnuraj R; Marbury TC; Alcorn HW; Fang E; Prokocimer P
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6471-6. PubMed ID: 25136024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tedizolid population pharmacokinetics, exposure response, and target attainment.
    Flanagan S; Passarell J; Lu Q; Fiedler-Kelly J; Ludwig E; Prokocimer P
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6462-70. PubMed ID: 25136028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid.
    Flanagan S; Fang E; Muñoz KA; Minassian SL; Prokocimer PG
    Pharmacotherapy; 2014 Sep; 34(9):891-900. PubMed ID: 24989138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
    Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, Safety, and Tolerability of Tedizolid Phosphate After Single-dose Administration in Healthy Korean Male Subjects.
    Kim Y; Kim A; Lee S; Choi SH; Lee DY; Song JS; Lee H; Jang IJ; Yu KS
    Clin Ther; 2017 Sep; 39(9):1849-1857. PubMed ID: 28865799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and Safety of Tedizolid after Single and Multiple Intravenous/Oral Sequential Administrations in Healthy Chinese Subjects.
    Chen R; Shen K; Chang X; Tanaka T; Li L; Hu P
    Clin Ther; 2016 Aug; 38(8):1869-79. PubMed ID: 27461846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of Tedizolid and Pseudoephedrine Administered Alone or in Combination in Healthy Volunteers.
    Flanagan S; Minassian SL; Prokocimer P
    J Clin Med; 2018 Jun; 7(6):. PubMed ID: 29899212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Pharmacodynamics of Tedizolid.
    Iqbal K; Milioudi A; Wicha SG
    Clin Pharmacokinet; 2022 Apr; 61(4):489-503. PubMed ID: 35128625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter- and intrasubject variability of the inflammatory response to segmental endotoxin challenge in healthy volunteers.
    Holz O; Tan L; Schaumann F; Müller M; Scholl D; Hidi R; McLeod A; Krug N; Hohlfeld JM
    Pulm Pharmacol Ther; 2015 Dec; 35():50-9. PubMed ID: 26545873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of Tedizolid in Plasma and Sputum of Adults with Cystic Fibrosis.
    Park AYJ; Wang J; Jayne J; Fukushima L; Rao AP; D'Argenio DZ; Beringer PM
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in gastric intramucosal hydrogen ion concentration following endotoxin challenge in the rat and the actions of nitric oxide synthase inhibitors.
    Lamarque D; Whittle BJ
    Clin Exp Pharmacol Physiol; 2001 Mar; 28(3):164-8. PubMed ID: 11207670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential release of matrix metalloproteinase-9 and nitric oxide following infusion of endotoxin to human volunteers.
    Albert J; Radomski A; Soop A; Sollevi A; Frostell C; Radomski MW
    Acta Anaesthesiol Scand; 2003 Apr; 47(4):407-10. PubMed ID: 12694137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of endotoxin on lactate metabolism in humans.
    Michaeli B; Martinez A; Revelly JP; Cayeux MC; Chioléro RL; Tappy L; Berger MM
    Crit Care; 2012 Jul; 16(4):R139. PubMed ID: 22839504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.